Shannon Wiley focuses her practice on healthcare regulatory and transactional matters with a specific emphasis in the pharmaceutical industry. Shannon provides clients with legal guidance steeped in a deep business understanding, such as assisting clients with the development of limited distribution networks, pharmacy services agreements, hub arrangements, data services arrangements, and GPO agreements. She advises clients on regulations such as the Anti-Kickback Statute, the Health Insurance Portability and Accountability Act (HIPAA), the Civil Monetary Penalty Law, and FDA regulations such as the Drug Supply Chain Security Act. Shannon also provides guidance on the healthcare regulatory aspects of mergers and acquisitions.
American Health Law Association (AHLA)
National Association of Specialty Pharmacies (NASP)
American Pharmacists Association (APhA)
National Infusion Center Association
Memphis Bar Association — Health Law Section, Chair (2019) and Board Member (2015-2019); CLE Committee, Chair (2015-2016)
Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners
Representation of TT Capital Partners (TTCP), NovaQuest Capital Management (NovaQuest) and Frist Cressey Ventures in its recapitalization and growth equity investment in InformedDNA, the nation’s largest provider of genetic services
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
We represented HealthTrust (Healthtrust Purchasing Group, L.P.) in its definitive agreement to acquire Resource Optimization & Innovation (ROi), a recognized leader in healthcare supply chain management.
Represented Consonance Capital Partners in the recapitalization of Orsini Pharmaceutical Services, LLC
Represented Community Pharmacy Partners in its investment by Altaris Capital Partners, LLC.
Served as lead healthcare regulatory counsel to Amazon (Nasdaq: AMZN) in its acquisition of PillPack
Provided healthcare regulatory and antitrust counsel to Avella Specialty Pharmacy in its sale to OptumRx
Represented Fred’s, Inc. in its sale of EntrustRx to CVS Health Corporation.
Represented Medical Specialties Distributors (MSD) to McKesson Corporation.
Mid-South Super Lawyers “Rising Star” (2013-2019)
Cecil C. Humphreys Law Review